Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | TDP2 | O95551 | 1/20 | 0.36 |
| ▸ | NSD2 | O96028 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31186207 | 1.00 | TSHR (0.36) | TSHRCYP1A2CYP2A6TDP2NSD2 | |
| SCHEMBL7626926 | 0.82 | CYP1A2 (0.39) | TSHRCYP1A2CYP2A6POLBACHE | |
| SCHEMBL6858668 | 0.81 | CYP1A2 (0.33) | TSHRCYP1A2CYP2A6TDP2NSD2 | |
| SCHEMBL21624583 | 0.81 | POLB (0.31) | CYP1A2POLB | |
| SCHEMBL22606956 | 0.81 | POLB (0.48) | CYP1A2TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL24940926 | 0.77 | TRPA1 (0.44) | TSHRCYP1A2TRPA1ATMACHE | |
| SCHEMBL9229801 | 0.77 | CYP3A4 (0.39) | TSHRCYP1A2CYP2A6TDP2NSD2 | |
| SCHEMBL16970797 | 0.77 | CYP3A4 (0.43) | TSHRPOLBNOS3NOS2 | |
| SCHEMBL9720717 | 0.77 | TDP2 (0.31) | TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL19812690 | 0.77 | ALDH1A1 (0.36) | TDP2NSD2HSP90AA1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110483581-B | Palladium complex containing diphosphine m-carborane ligand and preparation and application thereof | 上海应用技术大学 | 2021-05-11 | — | — | CN | claimed |
| WO-2024061796-A1 | POLYMERISABLE LIQUID CRYSTAL MEDIUM AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024042008-A1 | POLYMERIZABLE LIQUID CRYSTAL MATERIAL AND POLYMERIZED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2024-02-29 | — | — | WO | disclosed |
| EP-3668948-B1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2023-10-25 | — | — | EP | disclosed |
| US-11781069-B2 | Liquid-crystal medium | MERCK PATENT GMBH (DE) | 2023-10-10 | — | — | US | disclosed |
| US-20230263057-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE SAME, AND THE CONDENSED CYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-11706983-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-20230183571-A1 | LIQUID-CRYSTAL MEDIUM COMPRISING POLYMERIZABLE COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-06-15 | — | — | US | disclosed |
| WO-2023061903-A1 | POLYMERISABLE COMPOUND, POLYMERISABLE LC MATERIAL AND POLYMER FILM | MERCK PATENT GMBH (DE) | 2023-04-20 | — | — | WO | disclosed |
| EP-3784755-B1 | LIQUID CRYSTAL MIXTURE AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2022-06-15 | — | — | EP | disclosed |
| EP-3049506-B1 | COMPOUNDS AND MESOGENIC MEDIA | MERCK PATENT GMBH (DE) | 2017-06-14 | — | — | EP | disclosed |
| WO-2017071793-A1 | LIQUID-CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2017-05-04 | — | — | WO | disclosed |
| EP-2990459-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2017-04-26 | — | — | EP | disclosed |
| WO-2017045740-A1 | LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | WO | disclosed |
| WO-2017041893-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2017-03-16 | — | — | WO | disclosed |
| EP-3130651-A1 | LIQUID-CRYSTALLINE MEDIUM | Merck Patent GmbH (DE) | 2017-02-15 | — | — | EP | disclosed |
| EP-2935514-B1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2017-02-01 | — | — | EP | disclosed |
| EP-2922933-B1 | POLYMERISABLE COMPOUNDS AND THE USE THEREOF IN LIQUID-CRYSTAL DISPLAYS | MERCK PATENT GMBH (DE) | 2017-02-01 | — | — | EP | disclosed |
| US-5616441-A | AS ELECTRON TRANSFERRING COMPOUND; INCREASED PHOTOSENSITIVITY; WEAR AND HEAT RESISTANCE; SOLVENT SOLUBILITY; BINDER COMPATABILITY; COPIERS; LASER PRINTERS | MITA INDUSTRIAL CO., LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0708375-A1 | Tryptanthrine derivative and electrophotosensitive material | MITA INDUSTRIAL CO., LTD. (JP) | 1996-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230263057-A1 | LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE SAME, AND THE CONDENSED CYCLIC COMPOUND | CRY1, CCNE2, CRY2 | TSHR 4581/4885CYP1A2 1605/4885CYP2A6 2900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.